Skip to content
10-Q

Quarterly Report

TENET HEALTHCARE CORP THC

0000070318-25-000046

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 22, 2025 87.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 88.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 91.81M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 98.52M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $1.19B
Stock Repurchased Q3 2025 · Sep 30, 2024 $672M
Capex Q3 2025 · Sep 30, 2025 $646M
Capex Q3 2025 · Sep 30, 2024 $601M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $2.81B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $2.38B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.98B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.02B
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.01B
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.17B
Current Liabilities Q3 2025 · Sep 30, 2025 $4.56B
Current Liabilities Q3 2025 · Dec 31, 2024 $4.31B
Total Liabilities Q3 2025 · Sep 30, 2025 $20.72B
Total Liabilities Q3 2025 · Dec 31, 2024 $20.39B
Current Assets Q3 2025 · Sep 30, 2025 $7.81B
Current Assets Q3 2025 · Dec 31, 2024 $7.68B
Total Assets Q3 2025 · Sep 30, 2025 $29.42B
Total Assets Q3 2025 · Dec 31, 2024 $28.94B
Eps Diluted Q3 2025 · Sep 30, 2025 $3.86
Eps Diluted Q3 2025 · Sep 30, 2025 $11.28
Eps Diluted Q3 2025 · Sep 30, 2024 $4.89
Eps Diluted Q3 2025 · Sep 30, 2024 $29.27
Eps Basic Q3 2025 · Sep 30, 2025 $3.89
Eps Basic Q3 2025 · Sep 30, 2025 $11.37
Eps Basic Q3 2025 · Sep 30, 2024 $4.93
Eps Basic Q3 2025 · Sep 30, 2024 $29.56
Operating Income Q3 2025 · Sep 30, 2025 $889M
Operating Income Q3 2025 · Sep 30, 2025 $2.66B
Operating Income Q3 2025 · Sep 30, 2024 $1.09B
Operating Income Q3 2025 · Sep 30, 2024 $5.14B
Revenue Q3 2025 · Sep 30, 2025 $5.29B
Revenue Q3 2025 · Sep 30, 2025 $15.78B
Revenue restated Q3 2025 · Sep 30, 2024 $5.13B
Revenue restated Q3 2025 · Sep 30, 2024 $15.6B